How to comanage MIGS patients, Potentially reduce DR by manipulating microbial species, How to overcome barriers when buying or selling a practice, and much more available in our digital edition.
MIGS offer a middle option to manage glaucoma, filling the gap between topical medication and laser or filtration surgery. ODs need to understand which patients are the best candidates and how to manage patients postop.
Evidence has linked the functional activity of our microbiome to biological processes that influence human wellness. See what factors may have the potential to reduce DR severity in humans independently of hyperglycemia.
More and more ODs are struggling with determining how to transition in or out of practice ownership. Whether for a seller or purchaser, there are some important factors for both parties to understand before moving forward with their decisions.
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: %%Member_Busname%% %%Member_Addr%% %%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%
